XML 33 R10.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities:      
Net income $ 475,467 $ 546,593 $ 447,286
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation 33,657 33,481 30,959
Amortization 54,280 59,152 52,975
Equity in earnings of unconsolidated affiliates (120,667) (137,572) (117,134)
Partner distributions received from unconsolidated affiliate 120,849 131,170 125,534
Stock-based compensation 39,403 41,451 27,014
Provision for losses on receivables (701) 502 (101)
Deferred income tax benefit (46,489) (7,831) (1,036)
Net loss from investments 3,078 366 286
Change in other long-term liabilities 285 824 (420)
Change in other assets (6,039) 68 (1,449)
Contract costs capitalized, net of amortization (1,692) (2,455) (2,790)
Other (4,638) 1,538 912
Decrease (increase) in:      
Receivables from investment products (2,978) (3,765) (1,106)
Receivables (15,663) (53,944) (44,761)
Other current assets (5,194) (4,202) (6,407)
Advances due from unconsolidated affiliate 3,063 (3,083) (39,420)
Increase (decrease) in:      
Accounts payable 2,971 249 3,343
Accrued liabilities 32,166 27,016 21,097
Deferred revenue 4,961 3,543 (6,100)
Total adjustments 90,652 86,508 41,396
Net cash provided by operating activities 566,119 633,101 488,682
Cash flows from investing activities:      
Additions to property and equipment (39,191) (26,499) (54,448)
Additions to capitalized software (35,293) (26,037) (24,119)
Purchases of marketable securities (178,217) (216,260) (143,493)
Prepayments and maturities of marketable securities 160,981 194,769 155,110
Sales of marketable securities 179 327 842
Cash paid for acquisitions, net of cash acquired 0 (80,159) 0
Proceeds from insurance settlements 4,388 0 0
Other investing activities (2,656) (11,024) (1,388)
Net cash used in investing activities (89,809) (164,883) (67,496)
Cash flows from financing activities:      
Payments under revolving credit facility (40,000) 0 0
Borrowings under revolving credit facility 0 40,000 0
Payment of contingent consideration (868) (3,965) (633)
Purchase and retirement of common stock (344,723) (408,069) (427,001)
Proceeds from issuance of common stock 58,186 55,231 49,413
Payment of dividends (109,830) (105,516) (103,914)
Net cash used in financing activities (437,235) (422,319) (482,135)
Effect of exchange rate changes on cash, cash equivalents and restricted cash (17,474) (1,868) 4,129
Net increase (decrease) in cash, cash equivalents and restricted cash 21,601 44,031 (56,820)
Cash, cash equivalents and restricted cash, beginning of year 831,758 787,727 844,547
Cash, cash equivalents and restricted cash, end of year 853,359 831,758 787,727
Interest paid 815 554 612
Income taxes paid 192,514 154,268 121,987
Non-cash investing and financing activities      
Acquisition of businesses in current assets, property and equipment, current liabilities and other long-term liabilities 0 76,621 0
Dividends declared but not paid $ 58,051 $ 55,452 $ 53,127